149 related articles for article (PubMed ID: 37996860)
1. RIPK1 polymorphisms and expression levels: impact on genetic susceptibility and clinical outcome of epithelial ovarian cancer.
Wang X; Deng K; Tao J; Zou J; Du Y; Dai L
Cancer Cell Int; 2023 Nov; 23(1):290. PubMed ID: 37996860
[TBL] [Abstract][Full Text] [Related]
2. Genetic variants and expression of the TIM-3 gene are associated with clinical prognosis in patients with epithelial ovarian cancer.
Wu JL; Zhao J; Zhang HB; Zuo WW; Li Y; Kang S
Gynecol Oncol; 2020 Oct; 159(1):270-276. PubMed ID: 32694063
[TBL] [Abstract][Full Text] [Related]
3. Transcription factor FOXP3 gene variants affect epithelial ovarian carcinoma in the Han Chinese population.
Zhang Y; Xu L; Zhou B; Li Q; You D; Liu C; Song H; Wang Y; Song Y; Su M; Huang X; Yuan M; Lan Z; Wang W
Int J Clin Exp Pathol; 2018; 11(3):1684-1693. PubMed ID: 31938270
[TBL] [Abstract][Full Text] [Related]
4. The polymorphism rs4705342 in the promoter of miR-143/145 is related to the risk of epithelial ovarian cancer and patient prognosis.
Zhao J; Zuo W; Zhang Y; He C; Zhao W; Meng T
Front Oncol; 2023; 13():1122284. PubMed ID: 37081985
[TBL] [Abstract][Full Text] [Related]
5. Association between the rs11614913 variant of miRNA-196a-2 and the risk of epithelial ovarian cancer.
Song ZS; Wu Y; Zhao HG; Liu CX; Cai HY; Guo BZ; Xie YA; Shi HR
Oncol Lett; 2016 Jan; 11(1):194-200. PubMed ID: 26870188
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphisms in the Fas and FasL genes are associated with epithelial ovarian cancer risk and clinical outcomes.
Li Y; Hao YL; Kang S; Zhou RM; Wang N; Qi BL
Gynecol Oncol; 2013 Mar; 128(3):584-9. PubMed ID: 23234803
[TBL] [Abstract][Full Text] [Related]
7. [Polymorphisms of ERCC1 gene and outcomes in epithelial ovarian cancer patients with platinum-based chemotherapy].
Qi BL; Li Y; Wang N; Zhou RM; Hu P; Kang S
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):847-52. PubMed ID: 24444563
[TBL] [Abstract][Full Text] [Related]
8. Associations between
Huang X; Shen C; Zhang Y; Li Q; Li K; Wang Y; Song Y; Su M; Zhou B; Wang W
Dis Markers; 2019; 2019():8012979. PubMed ID: 31485280
[TBL] [Abstract][Full Text] [Related]
9. Association between
Zhang Y; Wang Y; Huang X; Li Q; Li K; You D; Song Y; Su M; Zhou B; Wang W
Biomark Med; 2019 Apr; 13(6):445-455. PubMed ID: 30929455
[No Abstract] [Full Text] [Related]
10. [Association of three single nucleotide polymorphisms of the E-cadherin gene with susceptibility to epithelial ovarian carcinoma].
Liang J; Li Y; Wang N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Apr; 25(2):183-6. PubMed ID: 18393242
[TBL] [Abstract][Full Text] [Related]
11. Prediction value of intercellular adhesion molecule-1 gene polymorphisms for epithelial ovarian cancer risk, clinical features, and prognosis.
Cai G; Ma X; Zou W; Huang Y; Zhang J; Wang D; Chen B
Gene; 2014 Aug; 546(1):117-23. PubMed ID: 23933413
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms and plasma levels of IL-27: impact on genetic susceptibility and clinical outcome of bladder cancer.
Zhou B; Zhang P; Tang T; Liao H; Zhang K; Pu Y; Chen P; Song Y; Zhang L
BMC Cancer; 2015 May; 15():433. PubMed ID: 26014498
[TBL] [Abstract][Full Text] [Related]
13. [Single nucleotide polymorphisms in cell cycle regulator p21 and p27 genes are associated with susceptibility to epithelial ovarian cancer].
Jin X; Kang S; Wang N; Xing YP; Li Y
Zhonghua Fu Chan Ke Za Zhi; 2008 Mar; 43(3):209-12. PubMed ID: 18788572
[TBL] [Abstract][Full Text] [Related]
14. The AA genotype of a L1C G842A polymorphism is associated with an increased risk for ovarian cancer.
Heubner M; Wimberger P; Kasimir-Bauer S; Otterbach F; Kimmig R; Siffert W
Anticancer Res; 2009 Aug; 29(8):3449-52. PubMed ID: 19661372
[TBL] [Abstract][Full Text] [Related]
15. Role of DNA repair and cell cycle control genes in ovarian cancer susceptibility.
Mohamed FZ; Hussien YM; AlBakry MM; Mohamed RH; Said NM
Mol Biol Rep; 2013 May; 40(5):3757-68. PubMed ID: 23277402
[TBL] [Abstract][Full Text] [Related]
16. RIPK1 polymorphisms alter the susceptibility to cervical Cancer among the Uyghur population in China.
Tuoheti Z; Han L; Husaiyin S; Liu X; Ma C; Niyazi M
BMC Cancer; 2020 Apr; 20(1):299. PubMed ID: 32272907
[TBL] [Abstract][Full Text] [Related]
17. Polymorphisms in the CASP8 gene and the risk of epithelial ovarian cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Gynecol Oncol; 2011 Sep; 122(3):554-9. PubMed ID: 21714991
[TBL] [Abstract][Full Text] [Related]
18. Correlation between polymorphisms in IGF2/H19 gene locus and epithelial ovarian cancer risk in Chinese population.
Zhang HB; Zeng Y; Li TL; Wang G
Genomics; 2020 May; 112(3):2510-2515. PubMed ID: 32045670
[TBL] [Abstract][Full Text] [Related]
19. INSR gene polymorphisms correlate with sensitivity to platinum-based chemotherapy and prognosis in patients with epithelial ovarian cancer.
Hu JL; Hu XL; Han Q; Guo AY; Wang CJ; Wen YY; Cang SD
Gene Ther; 2017 Jul; 24(7):392-398. PubMed ID: 28436941
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population.
Zhang Z; Zhou B; Wu Y; Gao Q; Zhang K; Song Y; Zhang L; Xi M
Immunogenetics; 2014 Feb; 66(2):85-92. PubMed ID: 24352695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
